CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Eli Lilly and Company Company Snapshot
Eli Lilly and Company operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other companies in this sector in UNITED STATES : Abbott Laboratories (2020 sales of $34.61 billion of which 34% was Medical Devices), Regeneron Pharmaceuticals Incorporated ($8.50 billion of which 58% was EYLEA), and Viatris Inc ($11.95 billion of which 71% was Developed markets).

Sales Analysis. Eli Lilly and Company reported sales of $24.54 billion for the year ending December of 2020. This represents an increase of 9.9% versus 2019, when the company's sales were $22.32 billion. Despite this increase, sales are still slightly below the level achieved in 2018, when Eli Lilly and Company reported sales of $24.56 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Eli Lilly and Company
  Stock Performance Chart for Eli Lilly and Company
 
  Stock Data: Recent Stock Performance:
  Current Price (4/16/2021): 189.25
(Figures in U.S. Dollars)
1 Week 2.6%   13 Weeks 2.7%  
4 Weeks -0.8%   52 Weeks 20.3%  
 
Eli Lilly and Company Key Data:
  Ticker: LLY Country: United States
  Exchanges: NYSE FRA LON MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 24,539,800,000
(Year Ending Jan 2021).
Employees: 35,000
  Currency: U.S. Dollars Market Cap: 181,034,657,500
  Fiscal Yr Ends: December Shares Outstanding: 956,590,000
  Share Type: Common Closely Held Shares: 1,718,105
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.